CollPlant Biotechnologies (CLGN) Non Operating Interest Expenses (2017 - 2021)

CollPlant Biotechnologies (CLGN) has reported Non Operating Interest Expenses for 5 consecutive years, with -$8000.0 the latest figure, recorded in Q3 2021.

• For the quarter ending Q3 2021, Non Operating Interest Expenses rose 27.27% year-over-year to -$8000.0; the trailing twelve-month figure through Sep 2021 stood at $7000.0 (down 99.85% YoY), and the FY2020 full-year result was $34000.0, down 98.97% from the prior year.
• Non Operating Interest Expenses held at -$8000.0 in Q3 2021 per CLGN's latest filing, from -$8000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $4.7 million in Q4 2019 and bottomed at -$1.4 million in Q3 2019.
• Historically, Non Operating Interest Expenses has averaged $316187.5 across 5 years, with a median of -$5000.0 in 2019.
• The sharpest annual moves came in 2018 and 2019: Non Operating Interest Expenses jumped 2700.0% in 2018, then sank 23283.33% in 2019.
• Over 5 years, Non Operating Interest Expenses stood at -$81000.0 in 2017, then surged by 2700.0% to $2.1 million in 2018, then jumped by 120.89% to $4.7 million in 2019, then slumped by 99.1% to $42000.0 in 2020, then plunged by 119.05% to -$8000.0 in 2021.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered -$8000.0, -$8000.0, and -$19000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.